General Information of the Compound
Compound ID
CP0911725
Compound Name
(4S,7S,13S,16S,19S,22S,25S,28S,31S)-4-((5S,8S,11S,14S,17S,20S,23S,26S,29S,35S,38S,42S,46S,49S,52S,55S,58S,61S)-20-((1H-indol-3-yl)methyl)-1-amino-49-(3-amino-3-oxopropyl)-8,14-bis(4-aminobutyl)-46-sec-butyl-5-carbamoyl-11,55-bis(3-guanidinopropyl)-23-((R)-1-hydroxyethyl)-17,26,35-tris(hydroxymethyl)-58-isopropyl-38,42,52,63-tetramethyl-29-(2-(methylthio)ethyl)-7,10,13,16,19,22,25,28,31,34,37,41,45,48,51,54,57,60-octadecaoxo-6,9,12,15,18,21,24,27,30,33,36,40,44,47,50,53,56,59-octadecaazatetrahexacontan-61-ylcarbamoyl)-31-acetamido-19-(4-aminobutyl)-22-sec-butyl-28-(2-carboxyethyl)-7-(3-guanidinopropyl)-13-(hydroxymethyl)-16-isobutyl-25-isopropyl-6,9,12,15,18,21,24,27,30-nonaoxo-5,8,11,14,17,20,23,26,29-nonaazatetratriacontane-1,34-dioic acid
    Show/Hide
Formula
C145H251N45O42S
Molecular Weight
3328.943
Canonical SMILES
CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(C)=O)C(C)C)[C@@H](C)CC)C(C)C)C(=O)NC[C@H](C)C(=O)NC[C@H](C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O
    Show/Hide
InChI
InChI=1S/C145H251N45O42S/c1-19-76(11)113(138(228)163-63-78(13)117(207)162-64-79(14)118(208)182-101(68-191)120(210)164-67-107(199)169-97(51-59-233-18)130(220)184-104(71-194)137(227)190-115(81(16)195)142(232)181-100(62-83-65-161-85-35-22-21-34-84(83)85)134(224)185-103(70-193)136(226)174-89(38-25-29-54-148)125(215)173-92(42-33-58-160-145(156)157)126(216)172-88(37-24-28-53-147)124(214)170-86(116(151)206)36-23-27-52-146)188-132(222)94(43-47-105(150)197)171-119(209)80(15)166-122(212)91(41-32-57-159-144(154)155)177-139(229)111(74(7)8)187-135(225)99(61-73(5)6)180-129(219)95(45-49-109(202)203)175-123(213)87(40-31-56-158-143(152)153)168-106(198)66-165-121(211)102(69-192)183-133(223)98(60-72(3)4)179-127(217)90(39-26-30-55-149)178-141(231)114(77(12)20-2)189-140(230)112(75(9)10)186-131(221)96(46-50-110(204)205)176-128(218)93(167-82(17)196)44-48-108(200)201/h21-22,34-35,65,72-81,86-104,111-115,161,191-195H,19-20,23-33,36-64,66-71,146-149H2,1-18H3,(H2,150,197)(H2,151,206)(H,162,207)(H,163,228)(H,164,210)(H,165,211)(H,166,212)(H,167,196)(H,168,198)(H,169,199)(H,170,214)(H,171,209)(H,172,216)(H,173,215)(H,174,226)(H,175,213)(H,176,218)(H,177,229)(H,178,231)(H,179,217)(H,180,219)(H,181,232)(H,182,208)(H,183,223)(H,184,220)(H,185,224)(H,186,221)(H,187,225)(H,188,222)(H,189,230)(H,190,227)(H,200,201)(H,202,203)(H,204,205)(H4,152,153,158)(H4,154,155,159)(H4,156,157,160)/t76-,77-,78-,79-,80-,81+,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,111-,112-,113-,114-,115-/m0/s1
    Show/Hide
InChIKey
DOXCGMUATNXNGM-GJISXZTKSA-N
Physicochemical Property
logP
-15.14229
Rotatable Bonds
120
Heavy Atom Count
233
Polar Areas
1448.7
Hydrogen Bond Donor Count
53
Hydrogen Bond Acceptor Count
47
Complexity
233

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
ChEMBL ID
CHEMBL4748601
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT05999, Relaxin receptor 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000708 OVCAR-5 Homo sapiens (Human)  1
1
EC50 = 37 nM
   TI
   LI
   LO
   TS